JAN 09, 2021 12:55 PM PST

Potential Bronchodilator for COPD diseases

WRITTEN BY: Nouran Amin

Although there is significant improvement in managing asthma and chronic obstructive pulmonary disease (COPD) diseases, there is still a strong need in controlling symptoms to prevent hospitalizations or even death.

"Only about 50 percent of asthmatics, and an even lower percentage of people with COPD, achieve adequate control of lung inflammation and airway constriction with currently available medications," said Stephen Liggett, MD, vice dean for research at the University of South Florida Morsani College of Medicine and a USF Health professor of medicine, molecular pharmacology and physiology, and biomedical engineering. "So, we're clearly missing something from our drug armamentarium to help all these patients."

Now, research has found a way to target certain receptors with a promising bronchodilator.

"The two key questions we asked were: 'Is it possible to find a more potent agonist that activates this receptor?' and 'Is it feasible to deliver by inhalation given the potencies that we find?'" said Dr. Liggett, the paper's senior author. "T5-8 was the bronchodilator agonist that worked best. There were a few others that were very good as well, so we now have multiple potential new drugs to carry out the next steps."

Findings were in ACS Pharmacology and Translational Science.

Learn more about COPD diseases:

"The biggest challenge we faced was not having a 3-D crystal structure of TAS2R5, so we had no idea exactly how agonist T5-1 fit into this mysterious bitter taste receptor," Dr. Liggett said. "By merging our strength in receptors, pharmacology, physiology, and drug development, our team was able to make the breakthrough."

"Having two distinct classes of drugs that work in different ways to open the airways would be an important step to help patients optimally control their symptoms."

"This study yielded a drug discovery that successfully meets most of the criteria needed to advance the compound toward its first trial as a potential first-in-class bronchodilator targeting airway receptor TAS2R5."

Source: Science Daily

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
JUN 15, 2022
Drug Discovery & Development
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
JUN 15, 2022
High Intensity Ultrasound Therapy Treats Localized Prostate Cancer
High-intensity-focused ultrasound (HIFU) can treat some men with prostate cancer instead of surgery or radiation therapy ...
JUN 20, 2022
Health & Medicine
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
JUN 20, 2022
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
The New England Journal of Medicine published results from a small study by researchers at New York’s Memorial Slo ...
JUL 01, 2022
Coronavirus
Nanobodies Could Protect Us From Every Variant
JUL 01, 2022
Nanobodies Could Protect Us From Every Variant
Immune reactive molecules called nanobodies, which are based on molecules found in llamas could offer robust protection ...
JUL 04, 2022
Cannabis Sciences
Study calls for Improved Cannabis Product Labeling Practices
JUL 04, 2022
Study calls for Improved Cannabis Product Labeling Practices
Large scale study of cannabis product labeling highlights a critical need for more informative and accurate product desc ...
JUL 07, 2022
Cell & Molecular Biology
Mini-Kidneys Reveal New Insights, Treatments for Multiple Disorders
JUL 07, 2022
Mini-Kidneys Reveal New Insights, Treatments for Multiple Disorders
Researchers have been able to use animal models to study human disease, but there are clear limitations to that approach ...
AUG 04, 2022
Cannabis Sciences
Medical Marijuana Research Expansion Act
AUG 04, 2022
Medical Marijuana Research Expansion Act
What is the Medical Marijuana Research Expansion Act, and how will it help the cannabis science community? Here's the de ...
Loading Comments...